206 related articles for article (PubMed ID: 19758615)
1. Prognostic impact of histological subtype on surgically treated localized renal cell carcinoma.
Teloken PE; Thompson RH; Tickoo SK; Cronin A; Savage C; Reuter VE; Russo P
J Urol; 2009 Nov; 182(5):2132-6. PubMed ID: 19758615
[TBL] [Abstract][Full Text] [Related]
2. Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage.
Keegan KA; Schupp CW; Chamie K; Hellenthal NJ; Evans CP; Koppie TM
J Urol; 2012 Aug; 188(2):391-7. PubMed ID: 22698625
[TBL] [Abstract][Full Text] [Related]
3. Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.
Leibovich BC; Lohse CM; Crispen PL; Boorjian SA; Thompson RH; Blute ML; Cheville JC
J Urol; 2010 Apr; 183(4):1309-15. PubMed ID: 20171681
[TBL] [Abstract][Full Text] [Related]
4. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
5. Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma.
Beck SD; Patel MI; Snyder ME; Kattan MW; Motzer RJ; Reuter VE; Russo P
Ann Surg Oncol; 2004 Jan; 11(1):71-7. PubMed ID: 14699037
[TBL] [Abstract][Full Text] [Related]
6. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome.
Krejci KG; Blute ML; Cheville JC; Sebo TJ; Lohse CM; Zincke H
Urology; 2003 Oct; 62(4):641-6. PubMed ID: 14550434
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases.
de Peralta-Venturina M; Moch H; Amin M; Tamboli P; Hailemariam S; Mihatsch M; Javidan J; Stricker H; Ro JY; Amin MB
Am J Surg Pathol; 2001 Mar; 25(3):275-84. PubMed ID: 11224597
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery.
Ghavamian R; Cheville JC; Lohse CM; Weaver AL; Zincke H; Blute ML
J Urol; 2002 Aug; 168(2):454-9. PubMed ID: 12131287
[TBL] [Abstract][Full Text] [Related]
9. Comparative Analysis of Smoking as a Risk Factor among Renal Cell Carcinoma Histological Subtypes.
Patel NH; Attwood KM; Hanzly M; Creighton TT; Mehedint DC; Schwaab T; Kauffman EC
J Urol; 2015 Sep; 194(3):640-6. PubMed ID: 25896558
[TBL] [Abstract][Full Text] [Related]
10. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.
Cheville JC; Lohse CM; Zincke H; Weaver AL; Blute ML
Am J Surg Pathol; 2003 May; 27(5):612-24. PubMed ID: 12717246
[TBL] [Abstract][Full Text] [Related]
11. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
12. Does chromophobe renal cell carcinoma have better survival than clear cell renal cell carcinoma? A clinical-based cohort study and meta-analysis.
Jiang HM; Wei JH; Zhang ZL; Fang Y; Zhou BF; Chen ZH; Lu J; Liao B; Zhou FJ; Luo JH; Chen W
Int Urol Nephrol; 2016 Feb; 48(2):191-9. PubMed ID: 26589610
[TBL] [Abstract][Full Text] [Related]
13. Localized non-conventional renal cell carcinoma: prediction of clinical outcome according to histology.
Kim SH; Yang HK; Moon KC; Lee ES
Int J Urol; 2014 Apr; 21(4):359-64. PubMed ID: 24224568
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
Kassouf W; Sanchez-Ortiz R; Tamboli P; Tannir N; Jonasch E; Merchant MM; Matin S; Swanson DA; Wood CG
J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729
[TBL] [Abstract][Full Text] [Related]
15. Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Tilki D; Nguyen HG; Dall'Era MA; Bertini R; Carballido JA; Chromecki T; Ciancio G; Daneshmand S; Gontero P; Gonzalez J; Haferkamp A; Hohenfellner M; Huang WC; Koppie TM; Lorentz CA; Mandel P; Martinez-Salamanca JI; Master VA; Matloob R; McKiernan JM; Mlynarczyk CM; Montorsi F; Novara G; Pahernik S; Palou J; Pruthi RS; Ramaswamy K; Rodriguez Faba O; Russo P; Shariat SF; Spahn M; Terrone C; Vergho D; Wallen EM; Xylinas E; Zigeuner R; Libertino JA; Evans CP
Eur Urol; 2014 Sep; 66(3):577-83. PubMed ID: 23871402
[TBL] [Abstract][Full Text] [Related]
16. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
17. Renal cell carcinoma in young and old patients--is there a difference?
Thompson RH; Ordonez MA; Iasonos A; Secin FP; Guillonneau B; Russo P; Touijer K
J Urol; 2008 Oct; 180(4):1262-6; discussion 1266. PubMed ID: 18707708
[TBL] [Abstract][Full Text] [Related]
18. Comparison of clinicopathologic parameters and oncologic outcomes between type 1 and type 2 papillary renal cell carcinoma.
Le X; Wang XB; Zhao H; Chen RF; Ge P
BMC Urol; 2020 Sep; 20(1):148. PubMed ID: 32933514
[TBL] [Abstract][Full Text] [Related]
19. Clinical and pathological features associated with prognosis in patients with papillary renal cell carcinoma.
Sukov WR; Lohse CM; Leibovich BC; Thompson RH; Cheville JC
J Urol; 2012 Jan; 187(1):54-9. PubMed ID: 22088335
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features of pathologic stage T1 renal cell carcinoma after radical nephrectomy.
Lau WK; Cheville JC; Blute ML; Weaver AL; Zincke H
Urology; 2002 Apr; 59(4):532-7. PubMed ID: 11927308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
